[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-363600-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-363600-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","identification-of-tumor-promoting-functions-of-the-homeobox-family-transcription-factor-msx1-in-cervical-cancer","Identification of tumor-promoting functions of the Homeobox family transcription factor MSX1 in cervical cancer","","Cervical cancer (CC) remains a major cause of cancer-related death, despite prevention via HPV vaccination and improved outcomes with early detection. The homeobox family transcription factor MSX1 is known to influence tissue development and can act as either a tumor suppressor or an oncogene, yet its role in CC is unclear. This study identifies MSX1 as a tumor-promoting factor in CC, showing de novo MSX1 expression in precancerous lesions and increased clonogenic and migratory capacities in CC cell lines.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/identification-of-tumor-promoting-functions-of-the-homeobox-family-transcription-factor-msx1-in-cervical-cancer/363600/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/identification-of-tumor-promoting-functions-of-the-homeobox-family-transcription-factor-msx1-in-cervical-cancer/363600.png","ImageObject",300,407,{"name":42,"@type":43},"Jasmine","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-20","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main goal of the study regarding MSX1 in cervical cancer?","Question",{"text":63,"@type":64},"To elucidate the role of the homeobox transcription factor MSX1 in cervical cancer and its precancerous stages.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does MSX1 behave in normal versus precancerous cervical tissue?",{"text":68,"@type":64},"Normal squamous epithelium is negative for MSX1, while precancerous lesions show de novo MSX1 expression.",{"name":70,"@type":61,"acceptedAnswer":71},"Which mechanisms are linked to MSX1-driven aggressiveness in CC cells?",{"text":72,"@type":64},"The study reports an MSX1-dependent induction of EMT and CUT&RUN results implicating RHO/RAC/CDC42 signaling, with FOS as a key downstream factor contributing to aggressiveness.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},363600,1790217926,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336478487870,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","[www.nature.com/cddiscovery](www.nature.com/cddiscovery)  \nARTICLE OPEN   \nIdentiﬁcation of tumor-promoting functions of the Homeobox family transcription factor MSX1 in cervical cancer  \nPaulina Brücker1,5, Svenja Horn 1,5, Shaishavi Jansari1,5, Marianna Kombou 1, Simon Eppich2, Udo Jeschke2,3, Samy Hakroush4, Stefan Küffer4, Sonja Fritzsche 1, Florian Wegwitz 1,6 ✉ and Julia Gallwas 1,6  \n© The Author(s) 2026  \n\n|  | Cervical cancer (CC) remains a leading cause of cancer-related mortality among women, particularly in underdeveloped or developing countries lacking adequate screening programs. Despite being highly preventable through HPV vaccinations and screening tests, and highly treatable when detected early, CC continues to pose a signiﬁcant health burden. MSX1, a transcription factor of the homeobox family, plays an important role in the development and differentiation of tissues, including the gynecological tract. Since MSX1 has been identiﬁed as both a tumor suppressor and an oncogene in tumorigenesis, but its function in CC remains elusive to date, the present study aims to elucidate the role of MSX1 in CC and its precancerous stages. Our results demonstrate that MSX1 acts as a tumor-promoting factor in CC. While normal squamous epithelium of the cervix is negative for MSX1, we observed de novo expression of MSX1 in precancerous lesions. We found that MSX1 expression enhances the clonogenicand migratory capacities of cervical cancer cell lines. Mechanistic insights revealed an MSX1-dependent induction of the epithelialto-mesenchymal transition (EMT), a process highly correlated with cancer development and progression. CUT&RUN sequencing data identiﬁed enriched signaling of the cytoskeletal modulators RHO/RAC/CDC42 in MSX1-expressing cells, potentially mediated by MSX1 . Additionally, FOS, a downstream effector of RHO, was found as a key factor contributing to CC aggressiveness. Interference with both RHO-signaling and FOS-mediated regulation completely reversed the aggressive phenotype of MSX1-expressing cells. In conclusion, our ﬁndings suggest that MSX1 plays a crucial role in cancer-related signaling pathways and may |  |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| have implications for the development of therapeutic approaches in cervical cancer. |  |  |\n|  | Cell Death Discovery (2026)12:270; [https://doi.org/10.1038/s41420-026-03191-y](https://doi.org/10.1038/s41420-026-03191-y) |  |\n|  |  |  |\n\nINTRODUCTION  \nCervical cancer (CC) is the fourth most common cancer among women globally and ranks as the eighth most common cancer overall [1] . In 2022, global records indicated over 600,000 new diagnoses of CC. Despite being highly preventable and treatable when detected early, CC remains a primary cause of cancerrelated deaths in women worldwide [2] . About 85% of these fatalities occur in underdeveloped or developing nations, where adequate screening is hindered by poor infrastructure and medical resources. Consequently, the mortality rate is 18 times higher in low and middle-income countries compared to wealthier nations [3] . Based on global cancer statistics (GLOBOCAN) in 2022, an estimated 94% of the 350,000 CC deaths were reported in lowand middle-income countries [1] .  \nHuman Papillomavirus (HPV) infection is a predominant cause of CC, with HPV DNA detected in ~95% of malignant cervical lesions. High-risk HPV serotypes, particularly types 16 and 18, are implicated in around 70% of cases [4] . Although HPV is a common sexually transmitted infection often cleared by the immune system, persistent cases can lead to malignant transformation [5] . The increased expression of viral oncogenes E6/E7, which  \ninactivate cellular proteins p53 and Rb, marks the transition from mild dysplasia to invasive cancer by disrupting normal cellular regulatory pathways [6] . Consequently, preventive measures suc","cbCaioPa9WwHJrYf","https://ap.wps.com/l/cbCaioPa9WwHJrYf","pdf",10383207,13,"English","# Introduction\n## Background on cervical cancer and HPV\n## Cervical anatomy and disease progression","[{\"question\":\"What is the main goal of the study regarding MSX1 in cervical cancer?\",\"answer\":\"To elucidate the role of the homeobox transcription factor MSX1 in cervical cancer and its precancerous stages.\"},{\"question\":\"How does MSX1 behave in normal versus precancerous cervical tissue?\",\"answer\":\"Normal squamous epithelium is negative for MSX1, while precancerous lesions show de novo MSX1 expression.\"},{\"question\":\"Which mechanisms are linked to MSX1-driven aggressiveness in CC cells?\",\"answer\":\"The study reports an MSX1-dependent induction of EMT and CUT\\u0026RUN results implicating RHO/RAC/CDC42 signaling, with FOS as a key downstream factor contributing to aggressiveness.\"}]","Identification of tumor-promoting functions of the Homeobox family transcription factor MSX1 in cervical cancer | PDF",1790152057,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1563a99c63f309a7d600e10675433171.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/721ae5ab0abdf0f649aebbc685f18893.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b500b3bc6b91cff4309a4127e713c84e.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2de4e73a4dbfccaf08fa3d1ae3878320.webp",980,1301]